News for Gerresheimer AG (GXI.DE)

Revenue: Increased by 11.6% from EUR466 million in Q1 2024 to EUR520 million in Q1 2025.Adjusted EBITDA: Grew by 13.1% from EUR81 million to nearly EUR92 milli

Apr 11, 2025 / 08:00AM GMTOperator Ladies and gentlemen, welcome to the publication Q1 2025 results conference call. I am George, the chorus call operator. (Ope

Gerresheimer AG (OTCPK:GRRMF) Q1 2025 Earnings Conference Call April 11, 2025 4:00 AM ETCompany ParticipantsGuido Pickert - Vice President, Corporate...

(Bloomberg) -- Donald Trump’s trade war has hit billions of dollars worth of potential mergers, acquisitions and initial public offerings in less than 24 hours. Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersMetro-North Is Faster Than Acela on NYC-New Haven Route After Signal UpdatesLocal Governments Vie for Fired Federal WorkersLondon Clears Final Hurdle for More High-Speed Trains to EuropeWhat Would ‘Transportation Abundance’ Look Like?Ticket platform StubHub Holdin

FRANKFURT/NEW YORK (Reuters) -A consortium including KKR and Warburg Pincus has submitted a non-binding bid for Gerresheimer AG, which makes pens used to inject weight loss drugs like Wegovy, two people with knowledge of the matter said. The group has submitted a bid at close to 90 euros a share, one of the people said, which would value the company at nearly 3.1 billion euros ($3.37 billion), according to LSEG data, against 2.65 billion euros as of Friday's close. Spokespeople for KKR and Warburg Pincus declined to comment.

(Bloomberg) -- A consortium consisting of Warburg Pincus and KKR & Co. are in talks to acquire Gerresheimer AG, the German maker of packaging for drugs and cosm...

Q4 Organic Revenue Growth: 5.4%Q4 Adjusted EBITDA Growth: 6.4%Q4 Adjusted Earnings Per Share Growth: 6.7%Full Year Organic Revenue Growth: 2.9%Full Year Adjust

Feb 26, 2025 / 09:00AM GMTOperator Ladies and gentlemen, welcome to the publication Q4 and full year 2024 results conference call. I am Vicky, the Chorus Call o

Gerresheimer AG (OTCPK:GRRMF) Q4 2024 Results Conference Call February 26, 2025 4:00 AM ETCompany ParticipantsGuido Pickert - Investor RelationsDietmar...

Germany stocks mixed at close of trade; DAX up 0.24%

Germany stocks higher at close of trade; DAX up 0.49%

Germany stocks mixed at close of trade; DAX down 0.18%

Germany stocks mixed at close of trade; DAX down 0.18%

Germany stocks mixed at close of trade; DAX down 0.23%

Germany stocks mixed at close of trade; DAX down 0.27%

Germany stocks lower at close of trade; DAX down 0.45%

Germany stocks mixed at close of trade; DAX up 1.44%

The syringes market is expected to exceed USD 24,101 million in 2024. The market is expected to exceed USD 56,694.2 million by 2033, with a robust CAGR of...

Germany stocks higher at close of trade; DAX up 0.02%